Wolters Kluwer Health's Unique Prescription Data Tapped by FDA in Effort to Advance Drug Safety
. In September 2006the Institute of Medicine Report entitled The F...Contact: Tom Kivett ... Kivett & Company Communications ... +1 212 727-2935 ... tkivett@kivettandco...
. In September 2006,
the Institute of Medicine Report entitled, "The Future of Drug Safety:
Promoting and Protecting the Health of the Public" was released and
outlined numerous ongoing and future activities designed to continue to
strengthen the FDA's drug safety program. The Office of Surveillance and
Epidemiology (OSE) contributes to this effort by evaluating drug risks and
promoting the safe use of drugs by the American people. Specific
recommendations in the IOM report addressed modernizing the drug safety
program and outlined activities designed to modernize the process of
pharmacovigilance, including activities for the expansion of database
resources. In furtherance of this effort and in conjunction with the
recommendations in the IOM report, FDA seeks to continue to access drug
utilization data in an outpatient setting at the national level in the U.S.